Lord's Mark Industries Limited has announced that it has received a manufacturing licence for an In Vitro Diagnostic Software (Software as a Medical Device – SaMD) for its Biomescan Analytics Platform. trillions of microorganisms that influence digestion, immunity, metabolism and overall health.
Scientific research increasingly links the gut microbiome with lifestyle disorders such as diabetes, obesity etc. By analysing an individual's gut microbiome through advanced bioinformatics, Biomescan provides comprehensive insights into microbial diversity, metabolic functions, disease susceptibility indicators and evidence-based personalised dietary recommendations.
